Improved quality of life in patients with no-option critical limb ischemia undergoing gene therapy with DVC1-0101

Critical limb ischemia (CLI) has a poor prognosis and adversely affects patients’ quality of life (QOL). Therapeutic angiogenesis may improve mobility, mortality, and QOL in CLI patients. However, the effectiveness of gene therapy on such patients’ QOL is unknown. DVC1-0101, a non-transmissible reco...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Sci Rep
Hlavní autoři: Matsumoto, Takuya, Tanaka, Michiko, Yoshiya, Keiji, Yoshiga, Ryosuke, Matsubara, Yutaka, Horiuchi-Yoshida, Kumi, Yonemitsu, Yoshikazu, Maehara, Yoshihiko
Médium: Artigo
Jazyk:Inglês
Vydáno: Nature Publishing Group 2016
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4945920/
https://ncbi.nlm.nih.gov/pubmed/27418463
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/srep30035
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky